TY - JOUR
T1 - Genome-Wide Association Study Meta-Analysis of 9619 Cases With Tic Disorders
AU - PGC TS Working Group
AU - 23andMe Research Team
AU - Strom, Nora I.
AU - Halvorsen, Matthew W.
AU - Grove, Jakob
AU - Ásbjörnsdóttir, Bergrún
AU - Luðvígsson, Pétur
AU - Thorarensen, Ólafur
AU - de Schipper, Elles
AU - Bäckmann, Julia
AU - Andrén, Per
AU - Tian, Chao
AU - Yu, Dongmei
AU - Sul, Jae Hoon
AU - Tsetsos, Fotis
AU - Nawaz, Muhammad S.
AU - Huang, Alden Y.
AU - Zelaya, Ivette
AU - Illmann, Cornelia
AU - Osiecki, Lisa
AU - Darrow, Sabrina M.
AU - Hirschtritt, Matthew E.
AU - Greenberg, Erica
AU - Muller-Vahl, Kirsten R.
AU - Stuhrmann, Manfred
AU - Dion, Yves
AU - Rouleau, Guy
AU - Aschauer, Harald
AU - Stamenkovic, Mara
AU - Schlögelhofer, Monika
AU - Sandor, Paul
AU - Barr, Cathy L.
AU - Grados, Marco
AU - Singer, Harvey S.
AU - Nöthen, Markus M.
AU - Hebebrand, Johannes
AU - Hinney, Anke
AU - King, Robert A.
AU - Fernandez, Thomas V.
AU - Barta, Csaba
AU - Tarnok, Zsanett
AU - Nagy, Peter
AU - Depienne, Christel
AU - Worbe, Yulia
AU - Hartmann, Andreas
AU - Budman, Cathy L.
AU - Rizzo, Renata
AU - Lyon, Gholson J.
AU - McMahon, William M.
AU - Batterson, James R.
AU - Cath, Danielle C.
AU - Atzmon, Gil
N1 - Publisher Copyright:
© 2024 Society of Biological Psychiatry
PY - 2024/10/9
Y1 - 2024/10/9
N2 - Background: Despite the significant personal and societal burden of tic disorders (TDs), treatment outcomes remain modest, necessitating a deeper understanding of their etiology. Family history is the biggest known risk factor, and identifying risk genes could accelerate progress in the field. Methods: Expanding upon previous sample size limitations, we added 4800 new TD cases and 971,560 controls and conducted a genome-wide association study (GWAS) meta-analysis with 9619 cases and 981,048 controls of European ancestry. We attempted to replicate the results in an independent deCODE genetics GWAS (885 TD cases and 310,367 controls). To characterize GWAS findings, we conducted several post-GWAS gene-based and enrichment analyses. Results: A genome-wide significant hit (rs79244681, p = 2.27 × 10−8) within MCHR2-AS1 was identified, although it was not replicated. Post-GWAS analyses revealed a 13.8% single nucleotide polymorphism heritability and 3 significant genes: BCL11B, NDFIP2, and RBM26. Common variant risk for TD was enriched within genes preferentially expressed in the cortico-striato-thalamo-cortical circuit (including the putamen, caudate, nucleus accumbens, and Brodmann area 9) and 5 brain cell types (excitatory and inhibitory telencephalon neurons, inhibitory diencephalon and mesencephalon neurons, and hindbrain and medium spiny neurons). TD polygenic risk was enriched within loss-of-function intolerant genes (p =.0017) and high-confidence neurodevelopmental disorder genes (p =.0108). Of 112 genetic correlations, 43 were statistically significant, showing high positive correlations with most psychiatric disorders. Of the 2 single nucleotide polymorphisms previously associated with TDs, one (rs2453763) replicated in an independent subsample of our GWAS (p =.00018). Conclusions: This GWAS was still underpowered to identify high-confidence, replicable loci, but the results suggest imminent discovery of common genetic variants for TDs.
AB - Background: Despite the significant personal and societal burden of tic disorders (TDs), treatment outcomes remain modest, necessitating a deeper understanding of their etiology. Family history is the biggest known risk factor, and identifying risk genes could accelerate progress in the field. Methods: Expanding upon previous sample size limitations, we added 4800 new TD cases and 971,560 controls and conducted a genome-wide association study (GWAS) meta-analysis with 9619 cases and 981,048 controls of European ancestry. We attempted to replicate the results in an independent deCODE genetics GWAS (885 TD cases and 310,367 controls). To characterize GWAS findings, we conducted several post-GWAS gene-based and enrichment analyses. Results: A genome-wide significant hit (rs79244681, p = 2.27 × 10−8) within MCHR2-AS1 was identified, although it was not replicated. Post-GWAS analyses revealed a 13.8% single nucleotide polymorphism heritability and 3 significant genes: BCL11B, NDFIP2, and RBM26. Common variant risk for TD was enriched within genes preferentially expressed in the cortico-striato-thalamo-cortical circuit (including the putamen, caudate, nucleus accumbens, and Brodmann area 9) and 5 brain cell types (excitatory and inhibitory telencephalon neurons, inhibitory diencephalon and mesencephalon neurons, and hindbrain and medium spiny neurons). TD polygenic risk was enriched within loss-of-function intolerant genes (p =.0017) and high-confidence neurodevelopmental disorder genes (p =.0108). Of 112 genetic correlations, 43 were statistically significant, showing high positive correlations with most psychiatric disorders. Of the 2 single nucleotide polymorphisms previously associated with TDs, one (rs2453763) replicated in an independent subsample of our GWAS (p =.00018). Conclusions: This GWAS was still underpowered to identify high-confidence, replicable loci, but the results suggest imminent discovery of common genetic variants for TDs.
KW - Genetic
KW - Genomic
KW - GWAS
KW - Psychiatric
KW - Tic disorder
KW - Tourette syndrome
UR - http://www.scopus.com/inward/record.url?scp=85209555084&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2024.07.025
DO - 10.1016/j.biopsych.2024.07.025
M3 - Article
C2 - 39389409
AN - SCOPUS:85209555084
SN - 0006-3223
JO - Biological Psychiatry
JF - Biological Psychiatry
ER -